Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 28;18(3):1559325820941323. doi: 10.1177/1559325820941323

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 6. — In vivo cardiac remodeling echocardiography analysis after injection of the CD@β-GP and hMSCs-CD@β-GP at 28 days postadministration. A, Left ventricular internal dimensions of systole and diastole (LVIDs and LVIDd). B, End systolic and diastolic volume (EVS and EVD) measurement. C, Fractional shortening. D, Determinations of ejection fraction and fractional area change and left ventricular posterior wall at systolic and diastolic sites. C indicates chitosan; D, dextran; hMSCs, human mesenchymal stem cells; β-GP, β-glycerophosphate. *p < 0.05. **p < 0.01. ***p < 0.001.